Celldex Therapeutics reported $369.23M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US USD 429.02M 27.15M
Amgen AMGN:US USD 63.7B 4.41B
Applied Genetic Technologies AGTC:US USD 57.33M 9.35M
Aptinyx Inc APTX:US USD 76.2M 16.1M
Biocept BIOC:US USD 51.1M 7.04M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Celldex Therapeutics CLDX:US USD 369.23M 33.74M
Cytrx CYTR:US USD 6.56M 2.16M
Glaxosmithkline GSK:US GBP 60.31B 28.73B
Immunogen IMGN:US USD 358.8M 63.5M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Newlink Genetics NLNK:US USD 79.21M 6.24M
Northwest Biotherapeutics NWBO:US USD 31.1M 3.58M
Seattle Genetics SGEN:US USD 3.62B 11.26M